Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ONCY
ONCY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ONCY ETF News Today | Earnings, Events & Price Alerts
ONCY News
Oncolytics Biotech Adjusts Clinical Trial Strategy
Feb 24 2026
seekingalpha
Global Oncology Market Expected to Reach $748.17 Billion
Feb 24 2026
PRnewswire
Global Oncology Market Expected to Reach $748.17 Billion
Feb 24 2026
Newsfilter
Oncolytics Biotech Receives FDA Fast Track Designation for Cancer Treatment
Feb 17 2026
PRnewswire
Oncolytics Biotech Receives FDA Fast Track Designation for Cancer Treatment
Feb 17 2026
PRnewswire
Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep
Feb 17 2026
Newsfilter
FDA's Accelerated Approval Framework Drives Cancer Treatment Advances
Feb 17 2026
Newsfilter
Oncolytics Biotech Receives FDA Fast Track Designation
Feb 05 2026
PRnewswire
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Globenewswire
FDA Accelerates Oncology Drug Approvals, Boosting Market Potential
Feb 05 2026
Newsfilter
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Newsfilter
Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep
Feb 04 2026
seekingalpha
Oncolytics Receives FDA Fast Track Designation for Pelareorep
Feb 04 2026
Newsfilter
Oncolytics Biotech Strengthens Leadership Amid FDA Approval Surge
Jan 30 2026
PRnewswire
Oncolytics Biotech's Breakthroughs in Cancer Treatment
Jan 30 2026
PRnewswire
Oncolytics Biotech Strengthens Leadership Amid FDA Approval Surge
Jan 30 2026
Newsfilter
Show More News
